Drug Trial Radar · NCT06494878
The PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity
Last checked: Nov 19, 2026Latest source record: Jul 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
8,805
Planned (sponsor's estimate)
Start
Jun 4, 2026
Primary completion
Sep 2030
Study completion Dec 2030
Sponsor
- Lead sponsor
- University of CalgaryAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Canadian Institutes of Health Research (CIHR); European Clinical Research Infrastructure Network
- First posted
- Jul 10, 2024
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Prevention
- FDA-regulated drug
- No
- Who can join
- Female only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of the PARTUM trial is to determine if taking low-dose aspirin daily for 6 weeks after delivery is similar (non-inferior) to usual care low-molecular-weight heparin injections to prevent venous thromboembolism (VTE: blood clots in the legs or lungs) for postpartum individuals with VTE risk factors.
Conditions
- Venous Thromboembolism
- Postpartum Period
- Aspirin
- Low Molecular Weight Heparin
Interventions
AspirinDrug
75-100 mg taken once daily by mouth.
Low-molecular-weight heparinDrug
Low-molecular-weight heparin injections daily as prescribed by the treating physician.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Symptomatic VTETime frame: 6 weeks
Locations
12 sites in 7 countries. Site status is shown where the registry gives one.
Association Hospitalière De Bruxelles Et De Schaerbeek - Centre Hospitalier Universitaire Brugmann
Brussels, Belgium · Not yet recruiting
Foothills Medical Centre
Calgary, Alberta, Canada · Recruiting
The Ottawa Hospital - General Campus
Ottawa, Ontario, Canada · Not yet recruiting
Hvidovre Hospital
Hvidovre, Capital Region, Denmark · Not yet recruiting
CHU de Nancy
Nancy, France · Not yet recruiting
APHP - Hôpital Port Royal
Paris, France · Not yet recruiting
CHU de Saint-Etienne
Saint-Etienne, France · Not yet recruiting
CHU de Toulouse
Toulouse, France · Not yet recruiting
Rotunda Hospital, RCSI Department of Obstetrics and Gynaecology
Dublin, Ireland · Not yet recruiting
UCD Centre for Human Reproduction, The Coombe Hospital
Dublin, Ireland · Not yet recruiting
Amsterdam UMC
Amsterdam, Netherlands · Not yet recruiting
Medical University of Warsaw
Warsaw, Poland · Not yet recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.